Michael J. Detke, MD
- 11Articles
- 31.6KReads
- 2002–2009Active
- 42Collaborators
- 207Citations
About
Michael J. Detke, MD, has published extensively on the use of duloxetine in the treatment of major depressive disorder, generalized anxiety disorder, and related conditions. His work includes clinical trials evaluating duloxetine’s efficacy, safety, tolerability, and impact on role functioning, sexual functioning, and painful physical symptoms in these populations. He has also contributed to studies addressing urinary side effects associated with duloxetine and its comparative safety versus other antidepressants. His research spans from 2002 to 2009 and covers depression, anxiety, schizophrenia/schizoaffective disorders, and somatoform disorders.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
